ACRS Q4 2020 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$2M+44.3% YoY

Gross Profit

$294,00018.6% margin

Operating Income

-$14M-858.2% margin

Net Income

-$13M-833.7% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+9.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$71M

Total Liabilities

$33M

Stockholders' Equity

$38M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+44.3%
Gross Profit	$294,000	$68,000	+332.4%
Operating Income	-$14M	-$18M	+22.7%
Net Income	-$13M	-$19M	+29.2%

Revenue Segments

Laboratory Research Revenue

$1M89%

Other Revenue

$167,00011%